"A systematic approach taken by a company involved making an assessment of internal capabilities, strengths, and needs before the selection process."
David Moyer
Advertisement
David Moyer is vice president of regulatory compliance at Fulcrum Pharma Developments
Articles by David Moyer
Advertisement
Latest Updated Articles
Criteria for Selecting a CMO: A Case StudyPublished: April 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
